000 | 01922 a2200577 4500 | ||
---|---|---|---|
005 | 20250517210233.0 | ||
264 | 0 | _c20190422 | |
008 | 201904s 0 0 eng d | ||
022 | _a1432-1750 | ||
024 | 7 |
_a10.1007/s00408-018-0113-y _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDragicevic, Sandra | |
245 | 0 | 0 |
_aThe Variants in the 3' Untranslated Region of the Matrix Metalloproteinase 9 Gene as Modulators of Treatment Outcome in Children with Asthma. _h[electronic resource] |
260 |
_bLung _c06 2018 |
||
300 |
_a297-303 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_a3' Untranslated Regions _xgenetics |
650 | 0 | 4 |
_aAcetates _xtherapeutic use |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 |
_aAnti-Asthmatic Agents _xtherapeutic use |
650 | 0 | 4 |
_aAsthma _xdrug therapy |
650 | 0 | 4 |
_aBronchodilator Agents _xtherapeutic use |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aCyclopropanes |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFluticasone _xtherapeutic use |
650 | 0 | 4 | _aForced Expiratory Volume |
650 | 0 | 4 | _aGenetic Variation |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMatrix Metalloproteinase 9 _xgenetics |
650 | 0 | 4 | _aNitric Oxide |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 |
_aQuinolines _xtherapeutic use |
650 | 0 | 4 | _aRespiration |
650 | 0 | 4 |
_aRespiratory Hypersensitivity _xgenetics |
650 | 0 | 4 | _aSequence Analysis, DNA |
650 | 0 | 4 | _aSlovenia |
650 | 0 | 4 | _aSulfides |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aVital Capacity |
700 | 1 | _aKosnik, Mitja | |
700 | 1 | _aDivac Rankov, Aleksandra | |
700 | 1 | _aRijavec, Matija | |
700 | 1 | _aMilosevic, Katarina | |
700 | 1 | _aKorosec, Peter | |
700 | 1 | _aSkerbinjek Kavalar, Maja | |
700 | 1 | _aNikolic, Aleksandra | |
773 | 0 |
_tLung _gvol. 196 _gno. 3 _gp. 297-303 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00408-018-0113-y _zAvailable from publisher's website |
999 |
_c28233491 _d28233491 |